Holdings
HighVista Strategies LLC
As of Jun 30, 2026, HighVista Strategies LLC reported 127 positions worth US$361M. Largest: Abivax Sa, Revolution Medicines, Inc. and Definium Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abivax Sa | 113K | US$15.1M | −223 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 66,983 | US$12.5M | −2,326 | Jun 30, 2026 |
| Definium Therapeutics, Inc. | 243K | US$11.4M | +57,028 | Jun 30, 2026 |
| Immunovant, Inc. | 278K | US$10.7M | +52,734 | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 30,210 | US$10.1M | +3,887 | Jun 30, 2026 |
| Relay Therapeutics, Inc. | 506K | US$9.47M | +84,354 | Jun 30, 2026 |
| Vaxcyte, Inc. | 150K | US$8.7M | +25,092 | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 260K | US$8.13M | +156K | Jun 30, 2026 |
| Liquidia Corporation | 97,896 | US$7.81M | −1,848 | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 189K | US$7.31M | −8,271 | Jun 30, 2026 |